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ARTICLES should deal with original research or reviews of topics defined in the aims of the journal. Radiotherapy and Oncology publishes original
material only. It is therefore understood that the content of the paper has not previously been published in the same or a similar form and that it is
not under consideration for publication elsewhere. The act of submitting a manuscript to the journal carries with it the right to publish that paper.
Radiotherapy and Oncology uses an online manuscript submission and peer review process.
Papers and correspondence should be submitted online at http://www.ees.elsevier.com/ro and the instructions on the site should be closely
followed. Authors may submit manuscripts and track their progress to final decision. Reviewers can download manuscripts and submit their reports
to the Editors electronically.
The full contact details for the Editorial Office are shown below:
Professor Jens Overgaard, M.D., Radiotherapy and Oncology Secretariat, Department of Experimental Clinical Oncology, Aarhus University
Hospital, No¨rrebrogade 44, Building 5, DK-8000 Aarhus C, Denmark (Tel.: +45 78 46 26 29; Fax: +45 86 19 71 09; E-mail: ro@oncology.dk)
TYPES OF PAPERS
1. Full length original papers (max. 3000 words)
Describe original scientific work in the field of radiation oncology or related areas. The content of the paper should be sufficient to reach valid
conclusions. Full papers should include a structured abstract and be divided into sections (Introduction; Materials and Methods; Results; Discussion;
References; Tables; Figures) and should not normally exceed 6 printed pages, including references and a maximum of 6 tables/figures. Additional
material can be submitted as supplementary files.
2. Short communications and Technical notes (max. 2000 words)
Provide a brief but complete account of a particular piece of work, e.g. Phase I or II study, and should in total be no longer than 4 printed pages,
normally including a maximum of 2 figures or tables. A summary of not more than 50 words should be included (not a structured abstract), but the
manuscript can have fewer subheadings (e.g. short introduction; materials and methods; results and discussion). Authors are advised to see a recent
issue of the journal for size and lay-out.
3. Review articles
Rigorous critical assessment of clinical and/or laboratory research in a field of interest to the journal and its subscribers. Reviews are normally
solicited by the editors, and it is suggested that authors wishing to contribute a review article contact the editor-in-chief.
4. Editorials and commentaries
Editorials and commentaries relate to articles in the journal or to issues of relevance for the readership. This type of communication is normally
solicited by the editors.
5. Letters to the Editor
On topics of current interest or comment upon material previously or simultaneously published in the journal. They should be limited to 500 words
and may include 1 table or figure.
6. Announcements
The inclusion of announcements, etc. is at the discretion of the Editors and the Publisher and subject to space availability. Request for inclusion of
meeting announcement should be send to the ESTRO secretariat (see address in journal).
Author inquiries
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal’s homepage at http://
www.elsevier.com/locate/radonc. For detailed instructions on the preparation of electronic artwork, please visit http://www.elsevier.com/
artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the
publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author FAQs at http://www.elsevier.
com/authorFAQ and/or contact Customer Support via http://support.elsevier.com
Language services. Authors who require information about language editing and copyediting services pre- and post-submission please visit http://
webshop.elsevier.com/languageediting or our customer support site at http://support.elsevier.com.
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